Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05663502 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv12
  2. Study sites: 7 to 8v11
  3. Study sites: 5 to 7v10
  4. Re-verified, no change to tracked fieldsv9
  5. Study sites: 4 to 5v8
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 3 to 4v7
  2. Study sites: 2 to 3v6
  3. Study sites: 1 to 2v5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 27, 2023 to May 10, 2023
    • Study description expanded, about 175 words
    • Site details revised
    v4
  5. Study sites: 0 to 1v3
  6. Start date: Mar 27, 2023 to Jun 27, 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AIDS Malignancy Consortium
19 trials monitored
See 1 trial at risk
Colorectal Cancer
3,394 trials monitored
See 159 trials at risk
Non-Hodgkin Lymphoma
2,013 trials monitored
See 115 trials at risk
Sarcoma
1,026 trials monitored
See 67 trials at risk
and 1 more disease
This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors related to HIV and cancers that occur commonly in people living with HIV.
Trial Details
NCT Number NCT05663502
Lead Sponsor AIDS Malignancy Consortium
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm, HIV Infection, Kaposi Sarcoma, Lymphoma, Malignant Solid Neoplasm, Multicentric Castleman Disease, Plasmablastic Lymphoma +4 more
Related terms Anus Neoplasms, Hematologic Neoplasms, HIV Infections, Lymphoma, Multi-centric Castleman's Disease, Plasmablastic Lymphoma, Sarcoma, Kaposi
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov